Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

NIH Funds Influenza Research and Surveillance Network

Published: Friday, April 11, 2014
Last Updated: Friday, April 11, 2014
Bookmark and Share
NIAID-supported centers integrate research to improve pandemic preparedness.

Influenza scientists at five sites in the United States are to receive funding from the National Institute of Allergy and Infectious Diseases (NIAID) to collaborate with investigators around the globe in a network designed to advance understanding of influenza viruses and how they cause disease.

In addition to basic research, investigators in the Centers of Excellence for Influenza Research and Surveillance (CEIRS) network also conduct domestic and international influenza surveillance studies with an emphasis on rapid characterization of viruses that have the potential to cause pandemics.

The first CEIRS network was launched in 2007 by NIAID, part of the National Institutes of Health. NIAID has announced awards of the new contracts to continue the program for seven years.

“The CEIRS network exemplifies NIAID’s dual mission of conducting basic and applied influenza research, while maintaining the ability to respond rapidly in the event of an emerging public health threat,” said NIAID Director Anthony S. Fauci, M.D. “CEIRS investigators have contributed greatly to our understanding of how influenza viruses emerge from wild and domestic animals, their adaptation to and global circulation throughout the human population and the interplay between the viruses and human immune responses.” Dr. Fauci added that the CEIRS network also played a critical role in the nation’s response to the 2009 H1N1 influenza pandemic by, for example, quickly characterizing the virus and performing pre-clinical testing of candidate vaccines.

The geographic range of sample collection sites will be more tightly focused than previously on those regions where new influenza viruses are likely to emerge and the network will further integrate basic research with surveillance data gathering, said CEIRS project officer Diane Post, Ph.D., of NIAID’s Division of Microbiology and Infectious Diseases.

“A key mission of the CEIRS network is to foster innovative and collaborative basic research on influenza viruses, including how they evolve and adapt to animal and human hosts. The information we gain could help us understand why influenza pandemics occur and could assist health officials in taking steps to mitigate outbreaks,” Dr. Post said.

Four of the new CEIRS contracts are to institutions that had received a 2007 award. One institution, Johns Hopkins University, will establish a new center. All will conduct surveillance and basic research projects. The network has a global reach, with collaborations established or planned at more than two dozen sites in Asia, Southeast Asia, the Middle East, South America, Europe and Australia. Funding for the first year of the contracts will total approximately $23 million.

“Proposed work from all five centers involves new and exciting research programs that hold the promise to answer fundamental questions pertaining to influenza in animals and people,” said Dr. Post.

The centers are based at

Emory University, Atlanta

Emory-UGA Center of Excellence for Influenza Research and Surveillance (CEIRS) External Web Site Policy
Walter Orenstein, M.D., principal investigator
Richard Compans, M.D., co-principal investigator

In partnership with the University of Georgia (UGA), Emory University studies will focus on surveillance of swine influenza viruses and investigations of swine immune responses to virus infection. With collaborators in China, animal surveillance efforts will include swine and poultry. Basic research projects at Emory-UGA CEIRS will include efforts to better understand the human immune response to influenza vaccination, including responses of pregnant women. Planned studies of long-lasting flu antibodies could aid in the development of influenza vaccines that would provide years-long immunity to multiple strains of flu.

Icahn School of Medicine at Mount Sinai, New York City

Center for Research on Influenza Pathogenesis (CRIP) External Web Site Policy
Adolfo Garcia-Sastre, Ph.D., principal investigator

CRIP will provide an active and comprehensive animal influenza surveillance structure and will contribute to better understanding of the range of animals that can be infected by various influenza viruses and virus ecology, and the factors leading to the generation of pandemics. Planned animal surveillance studies include surveys of marine mammals and wild birds in the Atlantic region; information from these surveys could shed light on virus evolution in animal reservoirs. Basic research will include continued investigations of virus-host interactions aimed at revealing why some influenza virus types cause more serious disease than others.

Johns Hopkins University, Baltimore

Richard Rothman, M.D., Ph.D., principal investigator
Andrew Pekosz, Ph.D., co-principal investigator

Investigators plan active and passive surveillance studies of human flu strains in the United States and Taiwan with the goal of rapidly identifying exactly which strains are circulating over the course of each flu season. This would allow annual influenza vaccines to better match the circulating strains. Among the basic research projects planned is one that will probe the impact of influenza virus infection on human respiratory epithelial cells.

St. Jude Children’s Research Hospital, Memphis, Tenn.

St. Jude Center of Excellence for Influenza Research and Surveillance
Richard Webby, Ph.D., principal investigator
Stacey Schultz-Cherry, Ph.D., co-principal investigator

Scientists will further their investigations into how certain avian influenza viruses, for example, H7N9 avian influenza, jump the species barrier and become capable of infecting people and other mammals, while others never make this leap. In addition to studying wild bird populations in Canada and the United States, scientists associated with the St. Jude CEIRS will conduct animal surveillance studies at sites in Bangladesh, China, Colombia and Egypt. Basic research on transmission of flu virus in swine will include studies of the aerodynamics of virus-containing particles.

University of Rochester Medical Center, Rochester, N.Y.

New York Influenza Center of Excellence (NYICE) External Web Site Policy
John Treanor, M.D., principal investigator
David Topham, Ph.D., co-principal investigator

Basic research projects include efforts to understand the full scope of human immune system reactions to infection and vaccination. A strong emphasis is on comprehensive analysis of the cells in the immune system that determine susceptibility to infection. A long-term goal is to improve the design of flu vaccines so that they provide better protection against illness. Other projects include collection of blood samples from adults and children with acute influenza and from household members without symptoms to better understand immune system responses over the course of illness or following exposure not resulting in illness. Investigators also plan to study how social media platforms might be used to collect real-time data on flu outbreaks.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

NIH Grantees Win 2015 Nobel Prize in Chemistry
The 2015 Nobel Prize in chemistry has been awarded to NIH grantees Paul Modrich, Ph.D., of the Howard Hughes Medical Institute and the Duke University School of Medicine, Durham, N.C.; and Aziz Sancar, M.D., Ph.D., of the University of North Carolina, Chapel Hill, N.C.,.
Thursday, October 08, 2015
NIH Announces High-Risk, High-Reward Research Awardees
NIH to fund 78 awards to support highly innovative biomedical research.
Wednesday, October 07, 2015
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Tuesday, October 06, 2015
NIH Funding Targets Gaps in Biomedical Research
New awards support emerging issues in cutting-edge biomedical research fields.
Tuesday, October 06, 2015
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Tuesday, October 06, 2015
Dormant Viral Genes May Awaken to Cause ALS
NIH human and mouse study may open an unexplored path for finding treatments.
Thursday, October 01, 2015
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
Thursday, October 01, 2015
Drug Used To Treat HIV Linked to Lower Bone Mass in Newborns
NIH study finds mothers’ use of tenofovir tied to lower bone mineral content in babies.
Wednesday, September 30, 2015
Repairing Nerve Pathways With 3-D Printing
A novel 3-D printing approach was used to create custom scaffolds that helped damaged rat nerves regenerate and improved the animals’ ability to walk.
Tuesday, September 29, 2015
Bone Risks Linked to Genetic Variants
A large-scale genomic study uncovered novel genetic variants and led researchers to an unexpected gene that affects bone density and fracture risk.
Tuesday, September 29, 2015
Genetic Adaptations to Diet and Climate
Researchers found genetic variations in the Inuit of Greenland that reflect adaptations to their specific diet and climate.
Tuesday, September 29, 2015
NIH Launches Landmark Study On Substance Use And Adolescent Brain Development
Thirteen grants awarded to look at cognitive and social development in approximately 10,000 children.
Monday, September 28, 2015
Grants to Help Identify Variants in the Genome’s Regulatory Regions
New computational approaches needed to wade through millions of inherited DNA differences to find which ones matter.
Thursday, September 24, 2015
Grants Awarded to Explore the Genome’s Regulatory Regions that Affect Disease Risk
New computational approaches needed to wade through millions of inherited DNA differences to find which ones matter.
Tuesday, September 22, 2015
NIH Framework Points The Way Forward For Developing The President’s Precision Medicine Initiative
The NIH Advisory Committee to the Director has presented to NIH Director Francis S. Collins, M.D., Ph.D., a detailed design framework for building a national research participant group, called a cohort, of 1 million or more Americans to expand our knowledge and practice of precision medicine.
Monday, September 21, 2015
Scientific News
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
How a Molecular Motor Untangles Protein
Diseases such as Alzheimer’s, Parkinson’s and prion diseases, all involve “tangled” proteins.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos